友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。
期刊名
Microbial Drug Resistance
MICROB DRUG RESIST
ISSN / eISSN
1076-6294 / 1931-8448
目标和范围
Microbial Drug Resistance (MDR) is an international, peer-reviewed journal that covers the global spread and threat of multi-drug resistant clones of major pathogens that are widely documented in hospitals and the scientific community. The Journal addresses the serious challenges of trying to decipher the molecular mechanisms of drug resistance. MDR provides a multidisciplinary forum for peer-reviewed original publications as well as topical reviews and special reports.
MDR coverage includes:
Molecular biology of resistance mechanisms
Virulence genes and disease
Molecular epidemiology
Drug design
Infection control.
MDR coverage includes:
Molecular biology of resistance mechanisms
Virulence genes and disease
Molecular epidemiology
Drug design
Infection control.
研究方向
传染病学
微生物学
药学
CiteScore
6.00
查看趋势图
CiteScore 学科排名
| 类别 | 分区 | 排名 |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics - Pharmacology | Q2 | #119/313 |
| Pharmacology, Toxicology and Pharmaceutics - Microbiology (medical) | Q2 | #56/140 |
| Pharmacology, Toxicology and Pharmaceutics - Microbiology | Q2 | #79/182 |
| Pharmacology, Toxicology and Pharmaceutics - Immunology | Q3 | #121/236 |
Web of Science 核心收藏夹
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| 类别 (Journal Citation Reports 2024) | 分区 |
|---|---|
| INFECTIOUS DISEASES | Q3 |
| MICROBIOLOGY | Q3 |
| PHARMACOLOGY & PHARMACY | Q3 |
H-index
62
出版国家或地区
UNITED STATES
出版商
Mary Ann Liebert Inc.
出版周期
Quarterly
出版年份
1995
年文章数
64
Open Access
NO
通讯方式
MARY ANN LIEBERT INC, 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started